Screener
Tarsus Pharmaceuticals, Inc. TARS Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s short-term investments?
- Tarsus Pharmaceuticals, Inc. (TARS) reported short-term investments of $245.1M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s short-term investments decreased by 13.8% year-over-year, from $284.5M to $245.1M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude